B
B

Biogen


News

Wall Street Journal - Sept 28

Sept 28 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Eleven of the world’s largest banks and brokerages will collectively pay $1.8 billion in fines to resolve regulatory investigations over their employees' use of messaging applications that broke record-keeping rules, regulators said Tuesday.
B
B
B
C
C
D
G
J
T
U
A

New York Times business news - Sept 28

Sept 28 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - Explosions under the Baltic Sea and the rupture of major natural gas pipelines from Russia to Germany appeared to be a deliberate attack, officials across Europe said on Tuesday, deepening uncertainty about European energy security amid soaring prices and fears of running short of fuel over the winter.
B

Wall Street Journal - Sept 27

Sept 27 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Pfizer Inc PFE.N and BioNTech SE 22UAy.DE asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years. - Ford Motor Co F.N is asking a Georgia court for a new trial, after a jury reached a $1.7 billion verdict against the auto maker last month involving a truck rollover accident that left
B
P
T

New York Times business news - Sept. 27

Sept 27 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - Currency emblazoned with the image of King Charles III is not expected to enter circulation until mid-2024, the Bank of England said in a statement released early Tuesday morning, though the portrait of the king to be featured on the bank notes will be revealed by the end of this year.
B

Japanese shares fall on energy rout, economic slowdown fears

TOKYO, July 6 (Reuters) - Japanese shares fell on Wednesday, with energy stocks leading losses, as sentiment was weighed by fears of a global economic slowdown. The Nikkei share average .N225 fell 1.26% to 26,089.86 by the midday break, while the broader Topix .TOPX slipped 1.37% to 1,853.41. "Investors' focus have shifted to slowdown risks stemming from the ongoing tightening monetary policy," said Ikuo Mitsui, fund manager at Aizawa Securities.
B
J

New York Times business news - May 4

May 4 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - Microsoft Corp's MSFT.O LinkedIn, the professional networking platform, has reached an agreement with the U.S. Department of Labor to pay $1.8 million to female employees who the agency said received far less compensation than their male colleagues from 2015 to 2017, the department said on Tuesday.
B
M
S

Wall Street Journal - April 8

April 8 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Walmart Inc WMT.N is raising starting pay for in-house truck drivers to as much as $110,000 a year and expanding a program that trains its existing workers to become drivers. Link - Tesla Inc TSLA.O Chief Executive Elon Musk delivered the company's first made-in-Texas vehicles on Thursday, saying the company was entering a new phase and
B
P
T

Wall Street Journal - Jan. 28

(Corrects link in first bullet point) Jan 28 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - U.S. President Joe Biden praised retiring Supreme Court Justice Stephen Breyer as a model public servant Thursday and reaffirmed his commitment to nominate a Black woman to fill his seat, pledging to make an announcement before the end of February.
B
M

Wall Street closes higher as inflation data supports Fed bets

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.) By Bansari Mayur Kamdar, Shreyashi Sanyal and Sinéad Carew Jan 12 (Reuters) - U.S. stock indexes rose on Wednesday after data showed that while U.S. inflation was at its highest in decades, it largely met economists' expectations, easing some fears that the Federal Reserve would have to pull back support even more forcibly than already expected.
B
C
J
U
U

New York Times business news - Jan. 12

Jan 12 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - Citigroup Inc C.N will exit its consumer banking business in Mexico, where it has more branches than in any other country, closing the curtain on an operation that was both extremely profitable and plagued by scandal.
B
C

Wall Street Journal - Jan. 12

Jan 12 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - U.S. President Joe Biden put his weight behind congressional Democrats' push to pass long-stalled elections bills, even if it requires changing Senate rules, in a speech Tuesday designed to build support for the imperiled legislation with votes just days away.
B
F

S&P 500, Dow score record highs as unemployment claims drop; strong manufacturing data

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.) * Weekly jobless claims fall more than expected * Biogen drops as Samsung BioLogics denies deal talk report * Disney on track to be the worst performing stock of the year * Dow up 0.07%, S&P 500 up 0.10%, Nasdaq up 0.41% By Echo Wang Dec 30 (Reuters) - The S&P 500 and the Dow touched all-time highs on Thursday, extending a record-setting run as new claims for U.S.
B
U
U

Eisai tumbles after government says Alzheimer's drug difficult to assess

** Shares of Eisai 4523.T tumble more than 9% in early trade ** A Japanese government panel said on Wednesday inconsistent trial results made it difficult to determine the efficacy of an Alzheimer's treatment developed by Eisai and Biogen Inc BIIB.O ** Eisai and Biogen have jointly developed three experimental drugs for the brain-wasting disease, which affects millions around the world and has not seen a new treatment in decades ** The U.S.
B

New York Times business news - Dec 21

Dec 21 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - At least 132 employees at SpaceX's Southern California headquarters tested positive for COVID-19, according to information posted on a Los Angeles County website. It was the highest number of cases currently reported among private companies in the county.
B
C

Futures flat on worries over supply chain disruptions; Netflix falls

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.) * Verizon rises on adding more postpaid subscribers * Baker Hughes falls as profit misses estimates * Anthem, Biogen gain on raising FY profit forecasts * Futures: Dow, S&P flat, Nasdaq up 0.10% By Devik Jain Oct 20 (Reuters) - U.S. stock index futures struggled for direction on Wednesday as investors weighed the impact of supply chain constraints and inflation on corporate earnings, whi
A
B
N
U
U



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.